Supreme Court of the United States
Skip Navigation LinksHome > Search Results



Docket for 18-817
Print  Notify Me  
Search documents in this case:
No. 18-817
 
Title: Hikma Pharmaceuticals USA Inc., et al., Petitioners
v.
Vanda Pharmaceuticals Inc.
Docketed: December 27, 2018
Linked with: 18A461
Lower Ct: United States Court of Appeals for the Federal Circuit
   Case Numbers: (2016-2707, 2016-2708)
   Decision Date: April 13, 2018
   Rehearing Denied: August 14, 2018
 
Proceedings and Orders
Oct 26 2018 Application (18A461) to extend the time to file a petition for a writ of certiorari from November 12, 2018 to December 27, 2018, submitted to The Chief Justice.
Main Document Lower Court Orders/Opinions Proof of Service
Oct 31 2018 Application (18A461) granted by The Chief Justice extending the time to file until December 27, 2018.
Dec 27 2018 Petition for a writ of certiorari filed. (Response due January 28, 2019)
Petition Appendix Certificate of Word Count Proof of Service
Jan 22 2019 Motion to extend the time to file a response from January 28, 2019 to February 12, 2019, submitted to The Clerk.
Main Document
Jan 23 2019 Motion to extend the time to file a response is granted and the time is extended to and including February 12, 2019.
Jan 28 2019 Brief amici curiae of Intellectual Property and Innovation Professors, Engine Advocacy, et al. filed.
Main Document Certificate of Word Count Proof of Service
Jan 28 2019 Brief amici curiae of The Association for Accessible Medicines and Certain Individual Companies filed.
Main Document Certificate of Word Count Proof of Service
Feb 12 2019 Brief of respondent Vanda Pharmaceuticals USA, Inc. in opposition filed.
Main Document Certificate of Word Count Proof of Service
Feb 26 2019 Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed.
Main Document Proof of Service Other
Feb 27 2019 DISTRIBUTED for Conference of 3/15/2019.
Mar 15 2019 Letter of Hikma Pharmaceuticals USA Inc., et al. received.
Main Document Proof of Service
Mar 18 2019 The Solicitor General is invited to file a brief in this case expressing the views of the United States.
May 22 2019 Amendment to Rule 29.6 Corporate Disclosure Statement filed with respect to brief in opposition of respondent Vanda Pharmaceuticals Inc.
Main Document
Dec 06 2019 Brief amicus curiae of United States filed.
Proof of Service Main Document
Dec 20 2019 Supplemental brief of petitioners Hikma Pharmaceuticals USA Inc., et al. filed.
Main Document Certificate of Word Count Proof of Service
Dec 23 2019 DISTRIBUTED for Conference of 1/10/2020.
Dec 23 2019 Supplemental brief of respondent Vanda Pharmaceuticals USA, Inc. filed. (Distributed)
Main Document Certificate of Word Count Proof of Service
Dec 26 2019 Letter of December 26, 2019 from counsel for petitioner received. (Distributed)
Main Document
Jan 13 2020 Petition DENIED.
Attorneys
Attorneys for Petitioners
Charles Bennett Klein
Counsel of Record
Winston & Strawn LLP
1700 K Street NW
Washington, DC 20006
cklein@winston.com
Ph: 202-282-5977
Party name: Hikma Pharmaceuticals USA Inc., et al.


Attorneys for Respondents
Nicholas Groombridge
Counsel of Record
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas
New York, NY 10019
ngroombridge@paulweiss.com
Ph: 212-373-3000
Party name: Vanda Pharmaceuticals USA, Inc.


Other Attorneys
Noel John Francisco
Counsel of Record
Solicitor General
United States Department of Justice
950 Pennsylvania Avenue, NW
Washington, DC 20530-0001
SUPREMECTBRIEFS!USDOJ.GOV
Ph: 202-514-2217
Party name: United States


Douglas Clifford Hochstetler
Counsel of Record
Kelley Drye & Warren LLLLP
333 West Wacker Drive, Suite 2600
Chicago, IL 60606-6402
DHochstetler@KelleyDrye.com
Ph: (312) 857-7070
Party name: THE ASSOCIATION FOR ACCESSIBLE MEDICINES AND CERTAIN INDIVIDUAL COMPANIES


Phillip Robert Malone
Counsel of Record
Juelsgaard Intellectual Property and Innovation Clinic
Mills Legal Clinic at Stanford Law School
559 Nathan Abbott Way
Stanford, CA 94305
pmalone@law.stanford.edu
Ph: 650-725-6369
Party name: Intellectual Property and Innovation Professors, Engine Advocacy, and The R Street Institute

 

Opinions
Filing & Rules
Oral Arguments
Case Documents
News Media
About
Visit
Contact Us | Site Map | Help | Fellows Program | Jobs | Links | Website Policies and Notices | Privacy Policy | USA.GOV
SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543